Seizure
[대역어] 압수
[용어속성] Term
[용어속성] Term
Castanospermine reduces Zika virus infection-associated seizure by inhibiting both the viral load and inflammation in mouse models
Research article
[키워드] Abnormalities
addition
Anti-viral
association
Brain
Brazil
castanospermine
combating
CST
disorders
immunosuppressive property
Infection
Inflammation
inhibiting
microcephaly
mouse model
neurological
neurological abnormalities
neuronal
Occurrence
outbreak
Outbreaks
paralysis
reduce
reduced
reported
resulting
Seizure
Spread
tissues
Viral load
Zika virus
ZIKV
[DOI] 10.1016/j.antiviral.2020.104935 [Article Type] Research article
[DOI] 10.1016/j.antiviral.2020.104935 [Article Type] Research article
Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19
Neurology
[키워드] age
Analysis
Anosmia
clinical
Cohort
coronavirus
COVID-19
death
defined
determine
disease course
Dizziness
eligible
Encephalopathy
for inclusion
headache
Hemorrhagic Stroke
hospital
hospitalized COVID-19 patient
hospitalized patient
independent
Infection
Laboratory
logistic regression model
Major
manifestation
Manifestations
Mortality
mortality rate
Multiple
multivariate
myalgias
neurological
Neurological disease
Neurological disorder
neurological manifestation
Patient
patients with COVID-19
predictor
Retrospective study
risk factor
Seizure
severity
stroke
vertigo
were recorded
were used
with COVID-19
women
[DOI] 10.3389/fneur.2020.585944 PMC 바로가기 [Article Type] Neurology
[DOI] 10.3389/fneur.2020.585944 PMC 바로가기 [Article Type] Neurology
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
중등도의 COVID-19 환자에서 멜라토닌의 효능 및 안전성 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
acute respiratory syndrome
Adverse drug reaction
Adverse drug reactions
alcohol
All study participants
allergy
allocation sequence
Alpha
anticipated
Antiviral
Arm
ARMS
assigned
Bandar Abbas
blinded
Blinding
block randomization
Breastfeeding
C-reactive protein
Chain Reaction
chronic hepatitis
cirrhosis
clinical
clinical symptom
Clinical symptoms
clinical trials
Clinicians
Computed tomography
conducted
Confirmed
Control
control group
Corticosteroids
COVID-19
COVID-19 pneumonia
criteria
Critical
Department
Depression
diabetes
Diabetes Mellitus
Diagnosis
Diseases
dissemination
dose
double-blind
drug
drugs
education
Efficacy and safety
element
evaluate
exclusion criteria
faculty
feature
generate
Hepatitis
history
Hospitalization
Hospitalized
hypertension
IL-1β
IL-6
ill patient
IMPROVE
incidence
inclusion criteria
inflammatory parameter
inflammatory parameters
Inflammatory responses
Informed consent
interleukin
interleukin-1β
Iran
liver diseases
Medical Sciences
Medicines
melatonin
Ministry of Health
number
Nurses
objective
outcome
oxygen
oxygen saturation
parallel-group
participant
Participants
Patient
patients
patients randomized
pharmaceutical
Pharmacy
Placebo
placebo-controlled clinical trial
Pneumonia
polymerase chain
polymerase chain reaction
polymerase chain reaction)
positive
Pregnancy
Primary outcome
Primary outcomes
protocol
random
randomization
Randomized
Randomized controlled trial
regimen
Registered
registration date
registration number
registry
Research
respiratory
Sample size
SARS-CoV-2
screened
secondary outcome
Secondary outcomes
Seizure
serum
Seven
Severe acute respiratory syndrome
single-center
standard treatment
status
Study protocol
the Faculty
therapeutic
treatment arm
trial protocol
Trial registration
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor-alpha
two group
two groups
underlying diseases
university
Version
Warfarin
web-based system
website
X-ray
[DOI] 10.1186/s13063-020-04737-w PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04737-w PMC 바로가기 [Article Type] Letter
Is Covid-19 lockdown related to an increase of accesses for seizures in the emergency department? An observational analysis of a paediatric cohort in the Southern Italy
Covid-19
[키워드] activities
Administered
Admission
Analysis
caused
changes
children
Cohort
concerning
COVID-19
DST
eligible
event
febrile
global pandemic
incidence
increase in
Italian
Italy
latency
lockdown
media
median age
MMD
Mobile media devices
negative correlation
overlapping
Patient
physical
Prevalence
Psychiatric disorders
questionnaire
reported
Result
screen time
Seizure
Seizures
sleep disorder
Spearman’s ρ
statistically significant difference
supplementary material
Trigger
TST
two groups
were excluded
WHO
World Health Organization
[DOI] 10.1007/s10072-020-04824-5 PMC 바로가기 [Article Type] Covid-19
[DOI] 10.1007/s10072-020-04824-5 PMC 바로가기 [Article Type] Covid-19
COVID-19 infection in known epileptic and non-epileptic children: what is the place of chloroquine sulfate? (a case report)
Case Report
[키워드] acute respiratory syndrome
Case report
Central nervous system
children
China
Chloroquine
chloroquine sulfate
complications
coronavirus
Coronavirus-2
COVID-19
COVID-19 infection
COVID-19 patient
disease
electroencephalogram
epilepsy
epileptic malaise
Epileptic seizures
equipment
facilitate
febrile
healthy
limit
management
occurred
Occurrence
pandemic
parents
Patient
patients
SARS-CoV-2
SARS-COV-2 infection
Seizure
Spread
the disease
Treatment
worsening
[DOI] 10.11604/pamj.2020.37.177.26066 PMC 바로가기 [Article Type] Case Report
[DOI] 10.11604/pamj.2020.37.177.26066 PMC 바로가기 [Article Type] Case Report
The neurological manifestations of COVID-19 – A case series
Original Article
[키워드] acute respiratory syndrome
case sery
cause
caused
clinician
Community
coronavirus
coronavirus disease
Course
CoV
COVID-19
diagnose
epilepsy
Features
General population
help
hospital
infective
information
involved
neurological invasion
neurological manifestation
Neurological symptoms
neurological system
outbreak
over
Patient
patients
patients with COVID-19
Pneumonia
presenting
presenting symptom
Relevance
reported
Respiratory illness
SARS-CoV
Seizure
Seizures
shown
structures
virus
PMC 바로가기 [Article Type] Original Article
PMC 바로가기 [Article Type] Original Article
SARS-COV-2 infection during pregnancy, a risk factor for eclampsia or neurological manifestations of COVID-19? Case report
Case Report
[키워드] affected
Antihypertensive treatment
blindness
blood pressure
Brain
C-section
Caesarean section
Case-report
Computed tomography
cortical
COVID-19
endothelial damage
Endothelium
facilitate
Infection
initiated
leukoencephalopathy
Manifestations
Neurological complication
neurological manifestation
neurological manifestations
normal pregnancy
pathophysiology
patient group
preeclampsia
Pregnancy
Pregnant woman
pregnant women
promote
resolved
respiratory
risk factor
Seizure
Symptom
[DOI] 10.1186/s12884-020-03275-2 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s12884-020-03275-2 PMC 바로가기 [Article Type] Case Report
Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
Research Article
[키워드] 95% CI
age
Anosmia
Ataxia
Chicago
consecutive patient
Course
discharge
disorders
Dizziness
Encephalopathy
examined
functional
headache
hospital
Hospitalization
Hospitalized
hospitalized patient
independent
independent predictor
Logistic regression
manifestation
Manifestations
mechanical ventilation
morbidity
morbidity and mortality
Mortality
multiple organ
myalgia
nervous system
neurologic
objective
occur
occurred
outcome
Patient
patients
Respiratory disease
Result
risk factor
Risk factors
scale
Seizure
severity
the disease
[DOI] 10.1002/acn3.51210 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1002/acn3.51210 PMC 바로가기 [Article Type] Research Article